A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years

Clinical trial NCT02212106 · COMPLETED

Trial details

NCT number: NCT02212106
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2014-09-01
Primary completion: 2014-12-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.